Established in 2011, Hangzhou JZCare Medical Co., Ltd. has emerged as a high-tech powerhouse in the medical consumables landscape. Operating a 26,000 m² state-of-the-art facility, we integrate R&D, precision molding, and automated assembly to serve the global healthcare infrastructure.
Our focus on Low Dead Space (LDS) technology and integrated needle bonding ensures maximum medication delivery efficiency. With over 300 specialists and advanced cleanroom environments, we maintain 100% compliance with ISO and CE international benchmarks.
With an annual capacity exceeding 1.5 Billion units, JZCare provides the scale required for national immunization programs and large-scale hospital group purchasing organizations (GPOs) across North America, Europe, and Asia.
The transition from traditional detachable needles to Integrated Needle Syringes represents a pivotal shift in clinical safety and pharmacoeconomics. Integrated needles are permanently bonded to the syringe barrel, eliminating the hub-needle interface where "dead space" typically occurs.
Modern integrated syringes utilize USP Type I Borosilicate Glass or high-clarity Medical Grade Polypropylene (PP). For cosmetic and pharmaceutical prefilled applications, the choice of material is critical to prevent leachables and extractables from interacting with sensitive biological agents.
Using advanced UV-cured adhesives and automated silicone coating processes, manufacturers like JZCare ensure that needle penetration force is minimized, significantly improving patient comfort. The "Integrated" nature means there is zero risk of the needle detaching during high-pressure injections.
In a world of expensive vaccines and biologics, saving even 0.05ml per dose is revolutionary. Integrated needle designs are the industry standard for dose-sparing technology, allowing healthcare providers to extract 10-20% more doses from a multi-dose vial compared to standard luer-lock configurations.
The global syringe market is shifting toward Safety-Engineered Devices (SEDs). Legislative mandates in the US (Needlestick Safety and Prevention Act) and EU are driving the adoption of integrated needles with passive retraction or shielding mechanisms.
The future lies in "Industry 4.0" factories. AI-driven quality inspection systems can now detect microscopic burrs on needles at a rate of 500 units per minute, ensuring that 100% of exported products meet surgical-grade standards.
Eco-friendly medical waste is the next frontier. We are researching bio-based polymers and reduced-plastic packaging to minimize the environmental footprint of billions of disposable units used annually.
While commonly used in general medicine, integrated needle syringes serve critical roles in specialized localized markets:
The resilience of the Chinese medical supply chain, specifically in hubs like Hangzhou, offers unparalleled advantages for global exporters and distributors:
Through vertically integrated manufacturing—where molding, needle grinding, assembly, and sterilization happen in one location—we reduce overhead and pass those savings to our global partners.
Our engineering teams can move from a design concept to a functional mold in weeks rather than months, allowing our clients to respond quickly to market changes or tender requirements.
JZCare adheres to the MDSAP (Medical Device Single Audit Program), ensuring our quality systems meet the requirements of Australia, Brazil, Canada, Japan, and the USA simultaneously.
Hangzhou JZCare Medical Co., Ltd. is committed to providing safe, efficient, and cost-effective medical disposable solutions while maintaining strong partnerships with international clients through stable quality and professional service support.
JZCare Syringe
